An observational study in Lactate, sponsored by Abbott Point of Care. Not yet recruiting at 3 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Abbott Point of Care (part of Abbott) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Assess precision of the i-STAT lactate test with the i-STAT CG4+ cartridge on the i-STAT 1 analyzer using two (2) separate capillary blood specimens.
The objective of this study is to assess the precision of the i-STAT lactate test using i-STAT CG4+ cartridge on the i-STAT 1 analyzer with two (2) separate capillary specimens for each subject enrolled in the study.
Abbott Point of Care is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
First submitted after Abbott Point of Care became part of Abbott.
Counted across the registry records on this site, refreshed daily.
Subjects from the intended use population.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Subject Inclusion Criteria
Exclusion Criteria:
Subject Exclusion Criteria
1. Previous enrollment in this study
Prospectively enrolled subjects in the intended use population.
Diagnostic Test: Fingerstick capillary blood draw
Fingerstick capillary blood draw
Precision across the reportable range for lactate
The primary outcome measure is to assess the precision across the lactate reportable range for the i-STAT lactate test using the i-STAT CG4+ cartridge on the i-STAT 1 analyzer.
Time frame: Through study completion, an average of 1 year
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for May 2027, 7 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.